161 related articles for article (PubMed ID: 21799046)
1. An assessment of bone fluoride and osteosarcoma.
Kim FM; Hayes C; Williams PL; Whitford GM; Joshipura KJ; Hoover RN; Douglass CW;
J Dent Res; 2011 Oct; 90(10):1171-6. PubMed ID: 21799046
[TBL] [Abstract][Full Text] [Related]
2. Fluoride exposure in public drinking water and childhood and adolescent osteosarcoma in Texas.
Archer NP; Napier TS; Villanacci JF
Cancer Causes Control; 2016 Jul; 27(7):863-8. PubMed ID: 27189068
[TBL] [Abstract][Full Text] [Related]
3. A case-control study of topical and supplemental fluoride use and osteosarcoma risk.
Hayes C; Douglass CW; Kim FM; Burgard SL; Couper D;
J Am Dent Assoc; 2021 May; 152(5):344-353.e10. PubMed ID: 33745682
[TBL] [Abstract][Full Text] [Related]
4. Bone fluoride levels, osteosarcoma risk not linked, study finds.
J Am Dent Assoc; 2011 Sep; 142(9):1005. PubMed ID: 21987835
[No Abstract] [Full Text] [Related]
5. Low levels of p53 mutations in Indian patients with osteosarcoma and the correlation with fluoride levels in bone.
Ramesh N; Vuayaraghavan AS; Desai BS; Natarajan M; Murthy PB; Pillai KS
J Environ Pathol Toxicol Oncol; 2001; 20(3):237-43. PubMed ID: 11797833
[TBL] [Abstract][Full Text] [Related]
6. Fluoride exposure and childhood osteosarcoma: a case-control study.
Gelberg KH; Fitzgerald EF; Hwang SA; Dubrow R
Am J Public Health; 1995 Dec; 85(12):1678-83. PubMed ID: 7503344
[TBL] [Abstract][Full Text] [Related]
7. Age-specific fluoride exposure in drinking water and osteosarcoma (United States).
Bassin EB; Wypij D; Davis RB; Mittleman MA
Cancer Causes Control; 2006 May; 17(4):421-8. PubMed ID: 16596294
[TBL] [Abstract][Full Text] [Related]
8. Serum fluoride and sialic acid levels in osteosarcoma.
Sandhu R; Lal H; Kundu ZS; Kharb S
Biol Trace Elem Res; 2011 Dec; 144(1-3):1-5. PubMed ID: 19390788
[TBL] [Abstract][Full Text] [Related]
9. A Case-Control Study of Fluoridation and Osteosarcoma.
Kim FM; Hayes C; Burgard SL; Kim HD; Hoover RN; ; Douglass CW; Couper D
J Dent Res; 2020 Sep; 99(10):1157-1164. PubMed ID: 32392084
[TBL] [Abstract][Full Text] [Related]
10. Evidence of selected nephrotoxic elements in Sri Lankan human autopsy bone samples of patients with CKDu and controls.
Ananda Jayalal TB; Mahawithanage STC; Senanayaka SMHMK; Dassanayaka PB
BMC Nephrol; 2020 Sep; 21(1):384. PubMed ID: 32883252
[TBL] [Abstract][Full Text] [Related]
11. p16 expression as a prognostic and predictive marker in high-grade localized osteosarcoma of the extremities: an analysis of 357 cases.
Righi A; Gambarotti M; Sbaraglia M; Sisto A; Ferrari S; Dei Tos AP; Picci P
Hum Pathol; 2016 Dec; 58():15-23. PubMed ID: 27544803
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets.
Folio C; Mora MI; Zalacain M; Corrales FJ; Segura V; Sierrasesúmaga L; Toledo G; San-Julián M; Patiño-García A
J Proteome Res; 2009 Aug; 8(8):3882-8. PubMed ID: 19492781
[TBL] [Abstract][Full Text] [Related]
13. A reproducibility study for a fluoride assay in bone.
Medina N; Douglass CW; Whitford GM; Hoover RN; Fears TR
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1035-7. PubMed ID: 16702389
[TBL] [Abstract][Full Text] [Related]
14. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
[TBL] [Abstract][Full Text] [Related]
15. Mitotic arrest defective protein 2 expression abnormality and its clinicopathologic significance in human osteosarcoma.
Yu L; Guo WC; Zhao SH; Tang J; Chen JL
APMIS; 2010 Mar; 118(3):222-9. PubMed ID: 20132188
[TBL] [Abstract][Full Text] [Related]
16. Lead and fluoride content in human bone and hair in the Gdańsk region.
Hać E; Czarnowski W; Gos T; Krechniak J
Sci Total Environ; 1997 Nov; 206(2-3):249-54. PubMed ID: 9394484
[TBL] [Abstract][Full Text] [Related]
17. Height at diagnosis and birth-weight as risk factors for osteosarcoma.
Mirabello L; Pfeiffer R; Murphy G; Daw NC; Patiño-Garcia A; Troisi RJ; Hoover RN; Douglass C; Schüz J; Craft AW; Savage SA
Cancer Causes Control; 2011 Jun; 22(6):899-908. PubMed ID: 21465145
[TBL] [Abstract][Full Text] [Related]
18. Vitronectin significantly influences prognosis in osteosarcoma.
Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma.
Dumars C; Ngyuen JM; Gaultier A; Lanel R; Corradini N; Gouin F; Heymann D; Heymann MF
Oncotarget; 2016 Nov; 7(48):78343-78354. PubMed ID: 27823976
[TBL] [Abstract][Full Text] [Related]
20. Is there a link between fluoridated water and osteosarcoma?
McGuire SM; Vanable ED; McGuire MH; Buckwalter JA; Douglass CW
J Am Dent Assoc; 1991 Apr; 122(4):38-45. PubMed ID: 2022786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
